参考文献/References:
[1].Guerrero-Romero F,Simental-Mendía LE,González-Ortiz M,et al. The product of triglycerides and glucose,a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp[J]. J Clin Endocrinol Metab,2010,95(7):3347-3351.
[2].Er LK,Wu S,Chou HH,et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals[J]. PLoS One,2016,11(3):e0149731.
[3].Mirr M,Skrypnik D,Bogdański P,et al. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR?show efficacy in diagnosing the metabolic syndrome[J]. J Endocrinol Invest,2021,44(12):2831-2843.
[4].Lim J,Kim J,Koo SH,et al. Comparison of triglyceride glucose index,and related parameters to predict insulin resistance in Korean adults:an analysis of the 2007—2010 Korean National Health and Nutrition Examination Survey[J]. PLoS One,2019,14(3):e0212963.
[5].Xie J,Zhang X,Shao H,et al. An affordable approach to classifying type 2 diabetes based on fasting plasma glucose,TyG index and BMI:a retrospective cohort study of NHANES Data from 1988 to 2014[J]. Diabetol Metab Syndr,2022,14(1):113.
[6].Guo X,Zhang X,Zheng L,et al. Prehypertension is not associated with all-cause mortality:a systematic review and meta-analysis of prospective studies[J]. PLoS One,2013,8(4):e61796.
[7].Schulman IH,Zhou MS. Vascular insulin resistance:a potential link between cardiovascular and metabolic diseases[J]. Curr Hypertens Rep,2009,11(1):48-55.
[8].Bala C,Gheorghe-Fronea O,Pop D,et al. The association between six surrogate insulin resistance indexes and hypertension:a population-based study[J]. Metab Syndr Relat Disord ,2019,17(6):328-333.
[9].Zeng ZY,Liu SX,Xu H,et al. Association of triglyceride glucose index and its combination of obesity indices with prehypertension in lean individuals:a cross-sectional study of Chinese adults[J]. J Clin Hypertens( Greenwich),2020,22(6):1025-1032.
[10].Samuel VT,Shulman GI.The pathogenesis of insulin resistance:integrating signaling pathways and substrate flux[J]. J Clin Invest,2016,126(1):12-22.
[11].宋晚美,刘曦峰,马小峰. 甘油三酯-血糖指数和甘油三酯-血糖-体质指数指数在冠心病预测和评估中的应用价值[J]. 中国循证心血管医学杂志,2021,13(6):680-683,691.
[12].Huang YC,Huang JC,Lin CI,et al. Comparison of innovative and traditional cardiometabolic indices in estimating atherosclerotic cardiovascular disease risk in adults[J]. Diagnostics(Basel),2021,11(4):603.
[13].Cheng Y,Fang Z,Zhang X,et al. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention:a retrospective study[J]. Cardiovasc Diabetol,2023,22(1):75.
[14].Jiang C,Yang R,Kuang M,et al. Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes[J]. Lipids Health Dis,2021,20(1):161.
[15].Wang X,Liu J,Cheng Z,et al. Triglyceride glucose-body mass index and the risk of diabetes:a general population-based cohort study[J]. Lipids Health Dis,2021,20(1):99.
[16].Song B,Zhao X,Yao T,et al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level:a population-based longitudinal cohort study[J]. Front Endocrinol(Lausanne),2022,13:907973.
[17].雷庆华,李军华,霍燕飞,等. 老年2型糖尿病患者甘油三酯葡萄糖指数与体重指数乘积与糖尿病发病率关系[J]. 科学技术与工程,2023,23(5):1882-1887.
[18].Nakanishi N,Yoshida H,Nakamura K,et al . Predictors for development of hyperuricemia:an 8-year longitudinal study in middle-aged Japanese men[J]. Metabolism,2001,50(6):621-626.
[19].Gu Q,Hu X,Meng J,et al. Associations of triglyceride-glucose index and its derivatives with hyperuricemia risk:a cohort study in Chinese general population[J]. Int J Endocrinol,2020,2020:3214716.
[20].Younossi ZM,Koenig AB,Abdelatif D,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence,incidence,and outcomes[J]. Hepatology,2016,64(1):73-84.
[21].de Freitas CM,Lage NN,de Souza PA,et al. Effects of a?ai on oxidative stress,ER stress,and inflammation-related parameters in mice with high fat diet-fed induced NAFLD[J]. Sci Rep,2019,9(1):8107.
[22].Li Y,Zheng R,Li J,et al. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels:a secondary analysis based on a prospective cohort study[J]. Lipids Health Dis,2020,19(1):229.
[23].Zhang S,Du T,Li M,et al. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects[J]. Medicine(Baltimore),2017,96(22):e7041.
[24].Wang R,Dai L,Zhong Y,et al. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease:insights from a general population[J]. Lipids Health Dis,2021,20(1):77.
[25].Hu H,Han Y,Cao C,et al. The triglyceride glucose-body mass index:a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population[J]. J Transl Med,2022,20(1):398.
[26].Otsubo N,Fukuda T,Genhin C,et al. Utility of indices obtained during medical checkups for predicting fatty liver disease in non-obese people[J]. Intern Med,2023,62(16):2307-2319.
相似文献/References:
[1]陈炜,许贞蓉.表观遗传学与代谢性心血管疾病的研究进展[J].心血管病学进展,2019,(6):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
CHEN Wei,XU Zhenrong.Epigenetics and Cardiometabolic Disease[J].Advances in Cardiovascular Diseases,2019,(7):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
[2]占小锋 张长磊 李刚.β肾上腺素受体阻滞剂对甘油三酯代谢的影响及其作用机制的阐述[J].心血管病学进展,2019,(9):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
ZHAN Xiaofeng,ZHANG Changlei,LI Gang.Effect of -adrenergic Receptor Blockers on Triglyceride Metabolism and Mechanism[J].Advances in Cardiovascular Diseases,2019,(7):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
[3]李莎 熊峰.胰岛素抵抗与心血管疾病研究进展[J].心血管病学进展,2019,(9):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
Li ShaXiong Feng.Insulin Resistance and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(7):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(7):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]任蕾 夏芳芳 戴红艳.血管生成素样蛋白6在心血管病方面的研究进展[J].心血管病学进展,2020,(4):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
REN Lei,XIA FangFang,DAI HongYan.Relationship Between ANGPTL6 and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(7):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
[6]杨晓倩 秦莉 张艺文 童兰 汪汉.糖皮质激素与心血管疾病[J].心血管病学进展,2020,(4):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Glucocorticoid and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(7):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
[7]樊德慧 金娟 韩宇博 田苗 刘莉.利钠肽与代谢综合征的研究进展[J].心血管病学进展,2020,(10):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
FAN Dehui,JIN Juan,HAN Yubo,et al.Research Progress of Natriuretic Peptide and Metabolic Syndrome[J].Advances in Cardiovascular Diseases,2020,(7):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
[8]廖丽萍 周跟东 张晓红.血清甘油三酯葡萄糖乘积指数与代谢性疾病的研究进展[J].心血管病学进展,2020,(11):1189.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[9]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(7):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[10]蔡薇 杨堰焯 刘昊凌.甘油三酯葡萄糖乘积指数与糖尿病血管病变的研究进展[J].心血管病学进展,2022,(3):245.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
CAI Wei,YANG Yanzhuo,LIU Haoling.Triglyceride-Glucose Index and Diabetic Vascular Disease[J].Advances in Cardiovascular Diseases,2022,(7):245.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]